XEL
65
-2
DOW
30
2
TAP
64
4
AA
38
-2
GS
75
-4
EMR
77
-2
DOV
73
4
ETR
68
-3
LRCX
46
-2
TXN
49
-6
BLK
70
-2
MRO
46
3
RCL
88
-2
IFF
53
2
BA
45
-3
REGN
42
-2
QCOM
55
-2
UA
57
4
MMM
42
5
DIS
62
2
XEL
65
-2
DOW
30
2
TAP
64
4
AA
38
-2
GS
75
-4
EMR
77
-2
DOV
73
4
ETR
68
-3
LRCX
46
-2
TXN
49
-6
BLK
70
-2
MRO
46
3
RCL
88
-2
IFF
53
2
BA
45
-3
REGN
42
-2
QCOM
55
-2
UA
57
4
MMM
42
5
DIS
62
2
Financhill
Back

scPharmaceuticals 10K Form

Sell
27

SCPH
scPharmaceuticals

Last Price:
3.31
Seasonality Move:
0.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-13 10Q SCPH/scPharmaceuticals Quarterly
2020-05-12 10Q SCPH/scPharmaceuticals Quarterly
2020-03-24 10K SCPH/scPharmaceuticals Annual
2019-11-12 10Q SCPH/scPharmaceuticals Quarterly
2019-08-07 10Q SCPH/scPharmaceuticals Quarterly
2019-05-08 10Q SCPH/scPharmaceuticals Quarterly

Receive SCPH News And Ratings

See the #1 stock for the next 7 days that we like better than SCPH

SCPH Financial Statistics

Sales & Book Value

Annual Sales: $13.59M
Cash Flow: $-20.23M
Price / Cash Flow: 0
Annual Sales: $0.26
Price / Book: 21.26

Profitability

EPS (TTM): -1.56000
Net Income (TTM): $-60.64M
Gross Margin: $9.78M
Return on Equity: -165.15%
Return on Assets: -66.11%

scPharmaceuticals Earnings Forecast

Key scPharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 2 years for SCPH is 71.96%.
  • The Selling, General & Administrative Expenses for SCPH have been equal to 392.62% of Gross Profit Margin.
  • The Research & Development expenses have been 86.88% of Revenue.
  • The Interest Expense is -14.82% of Operating Income.
  • The Net Earning history of SCPH is -403.22% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 3 years.

scPharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SCPH
CUSIP: 810648
Website: scpharmaceuticals.com

Debt

Debt-to-Equity Ratio: 4.32
Current Ratio: 4.84
Quick Ratio: 3.45

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SCPH Technical Analysis vs Fundamental Analysis

Sell
27
scPharmaceuticals (SCPH) is a Sell

Is scPharmaceuticals a Buy or a Sell?

  • scPharmaceuticals stock is rated a Sell
    The current scPharmaceuticals [SCPH] share price is $3.93. The Score for SCPH is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.